Alteration in ACE2 activity due to viral infection leads to a cascade of biological and pathological outcomes characterizing COVID-19 pathophysiology with the compromise of the respiratory tract and of other organs including cardiovascular damage, renal and gastrointestinal injury as well as increased incidence of thromboembolic events (Bourgonje et al., 2020). The gene discussed is ACE2; the disease is COVID-19.